[ad_1] Sign up to receive the most important news The Cabinet Media Center denied what was being reported on some websites and social media pages about the existence of a shortage of chronic disease medicines in hospitals of the global health insurance system. The Council of Ministers Media Center contacted …
Read More »COVID-19. The AstraZeneca vaccine could start being distributed in December in Europe
[ad_1] The pharmaceutical company in Portugal has already explained this vaccine trials are still ongoing and which are shared with the European Medicines Agency, which evaluates vaccine data as they become available. The company ensured that the authorities were aware of all relevant information and that, if the vaccine is …
Read More »what differences are there between the three vaccines against Covid-19?
[ad_1] The European Medicines Agency (EMA), which examines applications for authorization from three applicants, said on Monday it could approve the first vaccines against Covid-19 by the end of the year or early 2021. Oxford / AstraZeneca, Pfizer / BioNTech and Moderna are the three projects subject to this review. …
Read More »FDA approves emergency use of baritcinib with remdesivir for the treatment of Corona
[ad_1] The FDA today issued an Emergency Use Permit (EUA) for baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory-confirmed coronaviruses in hospitalized adults and pediatric patients two years of age or longer than required. Supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), according to …
Read More »Why Choose Junshi Biological Cooperation? Eli Lilly says science and data factors bear the brunt
[ad_1] Original title: Why choose Junshi Biological Cooperation? Eli Lilly says science and data factors bear the brunt Summary [Perché scegliere Junshi Biological Cooperation? Eli Lilly ha affermato che la scienza e i dati sono i primi a sopportare il peso]On the evening of November 12, Junshi Bio (688180, SH) …
Read More »Blockchain in the pharmaceutical market 2020: global analysis, industry growth, current trends and forecasts up to 2025
[ad_2][ad_1] “Blockchain in the pharmaceutical sector: market demand, growth, opportunities, producers and analysis of the main key players until 2025” PUNE, MAHARASHTRA, INDIA, November 11, 2020 /EINPresswire.com/ – Updated Research Report on Blockchain in the Pharmaceutical Market 2020-2025: Summary: Wiseguyreports.Com adds “Blockchain in the Pharmaceutical Industry: Market Demand, Growth, Opportunities, …
Read More »Meet the husband-wife pair behind Pfizer-BioNTech’s COVID-19 vaccine
[ad_1] (MENAFN – NewsBytes) US pharmaceutical giant Pfizer and German biotech firm BioNTech announced Monday that their COVID-19 vaccine candidate is over 90% effective based on initial data from a large study. Companies are the first to show successful data from a large-scale clinical trial for the vaccine. Behind this …
Read More »Blockchain in the pharmaceutical market to testify the robustness
[ad_2][ad_1] Blockchain in the pharmaceutical market Global Blockchain in the Growth State of the Pharmaceutical Market and 2020-2025 Outlook Given that blockchain technology allows for the secure creation and sharing of time-stamped records between numerous parties in real time, it is not surprising that it can be of interest to …
Read More »SAP launches the new Blockchain software to authenticate pharmaceutical products, eliminate counterfeit drugs
[ad_2][ad_1] SAP has recently launched a new blockchain system that would be used to track drugs and reduce counterfeit products on the market. The intention is to allow wholesalers to to authenticate pharmaceutical package. The supply chain in the pharmaceutical industry will be enhanced with the latest system developed by …
Read More »Teva Pharmaceutical Industries Limited (TEVA) – Bitcoin and stock newspaper
[ad_1] Teva Pharmaceutical Industries Limited (TEVA): As there was a brief look at the profitability, the company profit margin was recorded -56.00%, and the operating margin was noted at -59.00%. The company maintained a gross margin of 45.40%. The institutional property of the company is 59.90% while the insider's property …
Read More »